⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 28, 2024Journal of Medicinal Chemistry

Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer’s Disease

Lei Wang Tianyu Sun Tengfei Zhen Wei Li Huajing Yang Suyu Wang Feng Feng Yao Chen Haopeng Sun

View Full Paper

Ask AI

Bookmark

Share

Abstract

Butyrylcholinesterase (BChE) is a promising biomarker and effective therapeutic target for Alzheimer's disease (AD). Herein, we designed a BChE-activated near-infrared (NIR) probe,

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e71ecab6db6435876982c5 https://doi.org/10.1021/acs.jmedchem.4c00355

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rational design of environment-sensitive fluorescent probes for butyrylcholinesterase and their application in biological imagingOriginal Research · 2026 · 1 citations
2Rational design of a near-infrared fluorescent probe for monitoring butyrylcholinesterase activity and its application in development of inhibitors2024 · 6 citations
3Rational design of an environment-sensitive fluorescent probe for monitoring butyrylcholinesterase activity and its application in Alzheimer's diseaseOriginal Research · 2026
4Improved Affinity: A Customized Fluorescent Probe for the Rapid Detection of Butyrylcholinesterase2024 · 9 citations
5Theranostic advances in Alzheimer's disease: structure-guided design of near-infrared fluorescent probes targeting amyloid-β and cholinergic dysfunctionOriginal Research · 2026